JOHN VIERLING to Biopsy
This is a "connection" page, showing publications JOHN VIERLING has written about Biopsy.
Connection Strength
0.290
-
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. Pathology. 2022 Oct; 54(6):686-693.
Score: 0.145
-
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology. 2024 Oct; 167(5):1008-1018.e5.
Score: 0.042
-
Expert clinical management of autoimmune hepatitis in the real world. Aliment Pharmacol Ther. 2017 03; 45(5):723-732.
Score: 0.025
-
Malignant vascular tumors of the liver presenting as liver failure and portal hypertension. Liver Transpl Surg. 1995 May; 1(3):156-61.
Score: 0.022
-
Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med. 1994 Nov 15; 121(10):729-35.
Score: 0.022
-
Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol. 2006 Feb; 21(2):381-3.
Score: 0.012
-
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology. 2003 Aug; 125(2):298-303.
Score: 0.010
-
Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg. 1997 Jul; 3(4):398-406.
Score: 0.006
-
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc. 1996 Apr; 28(2):1011-3.
Score: 0.006